Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 2:10:76.
doi: 10.1186/1475-2875-10-76.

Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change

Guido J H Bastiaens  1 , Erik Schaftenaar, Arnold Ndaro, Monique Keuter, Teun Bousema, Seif A Shekalaghe
Affiliations

Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change

Guido J H Bastiaens et al. Malar J. .

Abstract

Background: Patterns of decreasing malaria transmission intensity make presumptive treatment of malaria an unjustifiable approach in many African settings. The controlled use of anti-malarials after laboratory confirmed diagnosis is preferable in low endemic areas. Diagnosis may be facilitated by malaria rapid diagnostic tests (RDTs). In this study, the impact of a government policy change, comprising the provision of RDTs and advice to restrict anti-malarial treatment to RDT-positive individuals, was assessed by describing diagnostic behaviour and treatment decision-making in febrile outpatients <10 years of age in three hospitals in the Kagera and Mwanza Region in northern Tanzania.

Methods: Prospective data from Biharamulo and Rubya Designated District Hospital (DDH) were collected before and after policy change, in Sumve DDH no new policy was implemented. Diagnosis of malaria was confirmed by RDT; transmission intensity was evaluated by a serological marker of malaria exposure in hospital attendees.

Results: Prior to policy change, there was no evident association between the actual level of transmission intensity and drug-prescribing behaviour. After policy change, there was a substantial decrease in anti-malarial prescription and an increase in prescription of antibiotics. The proportion of parasite-negative individuals who received anti-malarials decreased from 89.1% (244/274) to 38.7% (46/119) in Biharamulo and from 76.9% (190/247) to 10.0% (48/479) in Rubya after policy change.

Conclusion: This study shows that an official policy change, where RDTs were provided and healthcare providers were advised to adhere to RDT results in prescribing drugs can be followed by more rational drug-prescribing behaviour. The current findings are promising for improving treatment policy in Tanzanian hospitals.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Rubya DDH before policy change. AM = anti-malarial treatment given; AB = antibiotics given; NT = no treatment installed; RDT = rapid diagnostic test.
Figure 2
Figure 2
Rubya DDH after policy change. AM = anti-malarial treatment given; AB = antibiotics given; NT = no treatment installed; RDT = rapid diagnostic test.
Figure 3
Figure 3
Age specific seroprevalence plots for AMA-1 for Sumve, Biharamulo and Rubya. For Biharamulo two forces of infection were fitted for the other two sites one force of infection fitted the data best. The seroconversion rate (SCR, λ) for Sumve was 0.082 (95% CI 0.063-0.11). For Biharamulo the SCR was 0.34 (95% CI 0.19-0.61) for the period up to 1999 (i.e. for individuals older than 10 years of age) but 0.019 (95% CI 0.011-0.035) for the period 1999-2009. The SCR for Rubya was 0.041 (95% CI 0.029 - 0.058).
See this image and copyright information in PMC

References

    1. World Health Organization. World Malaria Report 2009. 2009.
    1. Amexo M, Tolhurst R, Barnish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet. 2004;364:1896–1898. doi: 10.1016/S0140-6736(04)17446-1. - DOI - PubMed
    1. Mboera LE, Makundi EA, Kitua AY. Uncertainty in malaria control in Tanzania: crossroads and challenges for future interventions. Am J Trop Med Hyg. 2007;77:112–118. - PubMed
    1. Mugittu K, Abdulla S, Falk N, Masanja H, Felger I, Mshinda H, Beck HP, Genton B. Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. Malar J. 2005;4:55. doi: 10.1186/1475-2875-4-55. - DOI - PMC - PubMed
    1. Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, Khalil IF, Theander TG, Lemnge MM, Bygbjerg IC. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene. Am J Trop Med Hyg. 2009;80:523–527. - PubMed